Clinical Trials

Phase 1 Active not recruiting

72 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04387084 2026-03-23

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

10 enrolled

Dermatologic

Skin Neoplasms

NCT05707910 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

Phase 1 Active not recruiting

6 enrolled

Tumor-Agnostic

Neoplasms

NCT05888402 2026-02-27

InTRist

50 enrolled

Local Advanced Non-small Cell Lung Cancer

NCT05518045 2026-02-04

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

392 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06771622 2026-02-04

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

Phase 2/3 Active not recruiting

500 enrolled

Solid Cancer

NCT06984588 2026-01-30

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

450 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06416696 2026-01-02

Toripalimab for High-risk Locally Advanced Cervical Cancer

57 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06584435 2025-12-19

TUORA

100 enrolled

Genitourinary

High-risk Renal Cell Carcinoma

NCT06293690 2025-12-18

Toripalimab Combined With SBRT for NSCLC

40 enrolled

Non-small Lung Cancer

NCT05975307 2025-12-01

BCIRT-01

Phase 2/3 Active not recruiting

71 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05980481 2025-09-29

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer

201 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06462222 2025-09-29

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

45 enrolled

CNS

Meningeal Carcinomatosis

NCT07047001 2025-07-09

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

60 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT04322006 2025-05-22

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Phase 1 Active not recruiting

376 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05167071 2025-04-27

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

53 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04517214 2025-04-02

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

100 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05869227 2024-12-30

Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

166 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06717464 2024-12-05

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

110 enrolled

Gastrointestinal

Gallbladder Neoplasms, Klatskin Tumor

NCT04418154 2024-05-21

NeoTENNIS

70 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

GastrointestinalOther solid neoplasm

25 enrolled

DMMR Colorectal Cancer

NCT04304248 2021-05-06

NeoTAP01

30 enrolled